HIV-1 viral infectivity factor interacts with microtubule-associated protein light chain 3 and inhibits autophagy. (28th January 2015)
- Record Type:
- Journal Article
- Title:
- HIV-1 viral infectivity factor interacts with microtubule-associated protein light chain 3 and inhibits autophagy. (28th January 2015)
- Main Title:
- HIV-1 viral infectivity factor interacts with microtubule-associated protein light chain 3 and inhibits autophagy
- Authors:
- Borel, Sophie
Robert-Hebmann, Véronique
Alfaisal, Jamal
Jain, Ashish
Faure, Mathias
Espert, Lucile
Chaloin, Laurent
Paillart, Jean-Christophe
Johansen, Terje
Biard-Piechaczyk, Martine - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective:</title> <p>Autophagy, an important antiviral process triggered during HIV-1 entry by gp41-dependent membrane fusion, is repressed in infected CD4<sup>+</sup> T cells by an unknown mechanism. The aim of this study was to identify the role of viral infectivity factor (Vif) in the autophagy blockade.</p> </sec> <sec> <title>Design/methods:</title> <p>To determine the role of Vif in autophagy inhibition, we used cell lines that express CD4 and CXCR4 and primary CD4<sup>+</sup> T cells. Pull-down experiments, immunoprecipitation assays and computational analyses were performed to analyze the interaction between Vif and microtubule-associated protein light chain 3B (LC3B), a major autophagy component, in presence or absence of the antiviral host factor apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G), after HIV-1 infection or ectopic expression of Vif. Autophagy was analyzed after infection by viruses expressing Vif (NL4.3) or not (NL4.3ΔVif), or after exogenous Vif expression.</p> </sec> <sec> <title>Results:</title> <p>We demonstrate that the C-terminal part of Vif interacts directly with LC3B, independently of the presence of APOBEC3G.Vif binds to pro-LC3 and autophagy-related protein 4-cleaved LC3 forms, and glycine 120, the amino acid conjugated to phosphatidylethanolamine on autophagosomes, is required. Importantly, we evidence that Vif inhibits autophagy<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objective:</title> <p>Autophagy, an important antiviral process triggered during HIV-1 entry by gp41-dependent membrane fusion, is repressed in infected CD4<sup>+</sup> T cells by an unknown mechanism. The aim of this study was to identify the role of viral infectivity factor (Vif) in the autophagy blockade.</p> </sec> <sec> <title>Design/methods:</title> <p>To determine the role of Vif in autophagy inhibition, we used cell lines that express CD4 and CXCR4 and primary CD4<sup>+</sup> T cells. Pull-down experiments, immunoprecipitation assays and computational analyses were performed to analyze the interaction between Vif and microtubule-associated protein light chain 3B (LC3B), a major autophagy component, in presence or absence of the antiviral host factor apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G), after HIV-1 infection or ectopic expression of Vif. Autophagy was analyzed after infection by viruses expressing Vif (NL4.3) or not (NL4.3ΔVif), or after exogenous Vif expression.</p> </sec> <sec> <title>Results:</title> <p>We demonstrate that the C-terminal part of Vif interacts directly with LC3B, independently of the presence of APOBEC3G.Vif binds to pro-LC3 and autophagy-related protein 4-cleaved LC3 forms, and glycine 120, the amino acid conjugated to phosphatidylethanolamine on autophagosomes, is required. Importantly, we evidence that Vif inhibits autophagy during HIV-1 infection. Indeed, autophagy is detected in target cells infected by NL4.3ΔVif, but prevented in cells infected by NL4.3. Furthermore, autophagy triggered in NL4.3ΔVif-infected cells is inhibited when Vif is expressed in <italic>trans</italic> but is still active when target cells express a mutant of Vif that binds weakly to LC3B.</p> </sec> <sec> <title>Conclusion:</title> <p>Our study unveils that Vif inhibits autophagy independently of its action on APOBEC3G and, therefore, suggest a new function of this viral protein in restricting innate antiviral mechanisms.</p> </sec> </abstract> … (more)
- Is Part Of:
- AIDS. Volume 29:Number 3(2015)
- Journal:
- AIDS
- Issue:
- Volume 29:Number 3(2015)
- Issue Display:
- Volume 29, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 29
- Issue:
- 3
- Issue Sort Value:
- 2015-0029-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-01-28
- Subjects:
- AIDS (Disease) -- Periodicals
Acquired Immunodeficiency Syndrome
AIDS (Disease)
Periodicals
Periodicals
616.9792005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00002030-000000000-00000 ↗
http://journals.lww.com/aidsonline/pages/default.aspx?desktopMode=true ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/QAD.0000000000000554 ↗
- Languages:
- English
- ISSNs:
- 0269-9370
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0773.083000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3535.xml